The effects of direct activators of protein kinase C (PKC) (the phorbol ester tetradecanoyl phorbol myristic acid [TPA] or bryostatin) on the ability of a highly enriched population of granulocyte-macrophage colony-forming cells (GM-CFC) to proliferate and develop in soft agar was assessed. In the absence of colony stimulating factors, the PKC activators did not stimulate colony formation. However, in the presence of optimal concentrations of granulocyte colony-stimulating factor (G-CSF) or interleukin-6 (IL-6). TPA or bryostatin markedly elevated the number of colonies formed from the GM-CFC. In the absence of TPA, IL-6, and G-CSF, respectively, both stimulated the formation of about 3% of the colonies observed when IL-3 was present. When TPA plus G-CSF or IL-6 were added together, this figure increased to 48% and 54%. respectively. In both instances, EVERAL hematopoietic growth factors have been shown S to stimulate the development of neutrophils and macrophages from the bipotential granulocyte-macrophage colony-forming cell (GM-CFC). These growth factors include interleukin-3 (IL-3; also known as multi-CSF), granulocytemacrophage colony-stimulating factor (GM-CSF), macrophage-CSF (M-CSF), IL-6, and granulocyte-CSF (G-CSF).' Although GM-CFCs are a common target cell for these growth factors, the biologic responses that are elicited can be markedly different. For example, IL-3 and GM-CSF can promote the development of both macrophages and neutrophils from GM-CFC, whereas M-CSF predominantly stimulates the formation of macrophages.'" Also, G-CSF'%2,4 and IL-647 can both promote the development of small colonies containing mature neutrophils and some macrophages from normal murine bone marrow, but the number of colonies produced in soft gel assays is a fraction of that seen when IL-3, GM-CSF, or M-CSF are used as the growth stimulus. However, it has been found that the majority of GM-CFCs are responsive to G-CSF and will undergo at least one round of DNA synthesis in response to this hematopoietic growth facto8 and it is unclear at present why only a limited number of G-CSF-stimulated GM-CFCs are capable of forming colonies in soft agar. the types of mature cells formed was altered from colonies of mature neutrophilic cells to a mixture consisting predominantly of macrophages with some neutrophils. Similar results were observed when bryostatin replaced TPA in these assays. When single cell colony-forming assays were performed, the same results were obtained. The presence of G-CSF, or IL-6, and the activator of PKC used (TPA or bryostatin) was required throughout the colony-forming assay for an optimal synergistic effect to be observed. These data indicate that agents that activate PKC can promote the proliferation and development of GM-CFC via a synergistic interaction with G-CSF or IL-6. Furthermore, there is an apparent role for PKC in development and possibly lineage commitment of GM-CFC.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 the types of mature cells formed was altered from colonies of mature neutrophilic cells to a mixture consisting predominantly of macrophages with some neutrophils. Similar results were observed when bryostatin replaced TPA in these assays. When single cell colony-forming assays were performed, the same results were obtained. The presence of G-CSF, or IL-6, and the activator of PKC used (TPA or bryostatin) was required throughout the colony-forming assay for an optimal synergistic effect to be observed. These data indicate that agents that activate PKC can promote the proliferation and development of GM-CFC via a synergistic interaction with G-CSF or IL-6. Furthermore, there is an apparent role for PKC in development and possibly lineage commitment of GM-CFC. One possibility is that a second growth factor is required for G-CSF to provide a sustained proliferative and developmental stimulus to GM-CFC: for example, several distinct combinations of CSF can act synergistically to promote formation of colonies containing mature myeloid and IL-6 can support the proliferation of some multipotent cells when a second growth factor, such as IL-3, is also added. Other examples of synergistic interactions between cytokines to promote myeloid cell development have also been reported.83' ' One set of compounds that has been shown to influence the proliferation and development of myeloid progenitor cells are the phorbol ester^'^-'^; compounds that can directly activate a number of calcium, phospholipid-dependent protein kinases (the protein kinase C [PKC] family), which are also activated by the action of some growth factors.I5 The ability of the phorbol esters to promote colony formation from myeloid progenitor cells may be attributable, at least in part, to the ability of PKC activators to stimulate the production of CSFs from accessory cells (such as fibroblasts and macrophages), present in colony-forming assays containing unfractionated normal bone marrow cells. However, phorbol esters can also potentiate the response of enriched populations of myeloid progenitor cells to hematopoietic growth factors such as GM-CSF by reducing the concentration of growth factor required for optimal levels of colony formation in soft agar assays.16 Furthermore, the incubation of enriched progenitor cells with phorbol esters has also been shown to promote the development of macrophages in the absence of any significant proliferation. I 7 A set of effects similar to those obtained with phorbol esters have been seen with bryostatin,'* another compound that is able to directly activate PKC, but does not have the tumor promoting effects of phorbol esters. '9-2' However, the colonystimulating activities of bryostatin have been suggested to be attributable to bryostatin-stimulated production of CSFs from accessory cell populations rather than through a direct effect on colony-forming ~e l l s .~~,~~ Using a highly enriched population of GM-CFC, we have attempted to assess the role of PKC activators on colony formation in the absence of accessory cells. 
MATERIALS AND METHODS
GM-CFCs from normal murine bone marrow were obtained as described by Cook et a12 based on the method described by Williams et al.' Briefly, mice were treated with cyclophosphamide, to increase the proportion of GM-CFC, 3 days before being killed. Bone marrow cells from the femora of these mice were then subjected to discontinuous density gradient centrifugation followed by elutriation centrifugation. When elutriated cells were plated in soft gel CFC-Mix assays, which would promote the development of colonies from other myeloid progenitor cells, greater than 95% of the colonies formed contained only neutrophils and/or macrophages, ie, the population is enriched for lineage-restricted neutrophil/macrophage progenitor cells (see Cook et a12 for further details). In soft gel GM-CFC assays, the plating efficiency observed in the presence of the growth factors IL-3, GM-CSF, or M-CSF (or combinations thereof) was 30%; see Cook et a12 and Williams et al' for details.
Soft agar-based colony-forming assays were performed as described previou~ly.~~ Elutriated GM-CFC were cultured in Iscove's medium plus 20% (vol/vol) fetal calf serum (FCS) (Northumbria Biologicals, Cramlington, Northumberland, UK), 0.33% agar and the appropriate growth factors and other additives in 35 mm Petri dishes (250 to 500 cells/dish). In some experiments, GM-CFCs were also plated in microtiter wells in a total volume of 0.25 mL (limiting dilutions were performed to obtain only 1 cell/ well). Cultures were incubated in fully humidified conditions in an atmosphere of 5% COz in air. Colonies (>SO cells) were counted at 7 days. In liquid culture, GM-CFCs were cultured in 20% (vol/vol) FCS in Iscove's medium plus other growth factors as described below. For morphologic analysis, cytospin preparations were made and stained with May-Grunwald-Giemsa stain.
['HI-thymidine incorporation assays.
['HI-thymidine incorporation assays were performed as previously described?
Growth factors. Purified native or recombinant growth factors were used in all the experiments described. Purified recombinant IL-3 (1.25 X lo6 U/mg protein) and GM-CSF (2. I X lo7 U/mg protein) were provided by Glaxo (Geneva, Switzerland). Recombinant human G-CSF (1 X 10' U/mg protein) was a gift from Amgen (Thousand Oaks, CA). Recombinant IL-6 was a gift from Amersham International (Bucks, UK). Native M-CSF was purified from L cell conditioned medium (to stage 4) using the method of Stanley and Heard?& Tetradecanoyl phorbol acetate (TPA) was purchased from Sigma, and bryostatin 1 was a gift from Dr W.S. Mays. Each growth factor used was assayed for colony-stimulating activity using GM-CFC. The concentration used was optimal for colony formation from GM-CFC unless otherwise stated.
Preparation of GM-CFC.
Colony-forming assays.
RESULTS
The effects of T P A on colony formation by highly enriched GM-CFC. When GM-CFC were plated out in soft agar colony forming assays in the presence of TPA (0.1 to 100 ng/ mL) no colonies were seen at either 7 or I4 days of incubation.
When added with hematopoietic growth factors (at concentrations of the growth factors that gave maximal levels of colony formation), different effects on the plating efficiency of the GM-CFC were observed depending on which growth factors were present.
There was no significant effect on the number of colonies formed in the presence of M-CSF or GM-CSF (Fig I) . However, in the case of IL-3-stimulated colony formation, there was a 63% increase in the number of colonies present when optimal concentrations of TPA (100 ng/mL) were added. Higher concentrations of this phorbol ester inhibited colony formation. M-CSF, IL-3, and GM-CSF all stimulated a similar level of plating efficiency in GM-CFC (Fig l) , which we have previously shown to be about 30%.2 However, the addition of TPA to colony-forming assays in the presence of G-CSF (5,000 U/mL) stimulated a dramatic increase in the number of colonies formed over the 7 day incubation. In the absence of TPA, G-CSF stimulated the development of only 3% k 2% of the colonies that are produced in the presence of IL-3. When optimal concentrations of TPA were present, this figure increased to 48%. Similarly, optimal concentrations of IL-6 gave only 4% of the colony-forming efficiency seen when IL-3 was added, but when IL-6 plus TPA (100 ng/mL) was added there was an increase to 54% of the IL-3-treated control incubations.
The addition of relatively low doses of G-CSF or IL-6 with TPA led to a large increase in the number of colonies formed, although the optimal level of colony formation was still ob- ) served at about 5,000 to 10,000 U G-CSF/mL and 100 U IL-6/mL (Fig 2) . The efec~s qf hryoslalin on colony .formalion h.v GM-CFC. We have also examined the effects of a second direct activator of PKC on the plating efficiency of GM-CFC in the presence of G-CSF or IL-6. Bryostatin (IO-'* to IO-' mol/L) alone did not stimulate either cluster or colony formation from GM-CFC. However, bryostatin (used at a concentration of lo-' mol/L, which was optimal for stimulation of colony formation in the presence of G-CSF) plus G-CSF gave 27% of the colonies observed with IL-3 compared with G-CSF alone, which gave 3% (Fig 3) . There was a similar synergistic interaction between IL-6 and bryostatin (IO-' mol/L); the number of colonies formed was elevated approximately sixfold compared with cultures in which IL-6 alone was added (Fig 3) . In the presence of G-CSF or IL-6 alone, the number of clusters formed were generally less than 5% of the total cells seeded and, as such, bryostatin-mediated or TPA-mediated conversion of clusters to colonies cannot account for the increased number of colonies observed.
The eflect of TPA and bryoslatin on single cell colonyforming assays. Although the elutriated cells are highly enriched for GM-CFC, it is possible that some of the effects that are observed are attributable to the presence of low numbers of contaminatory "accessory" cells. Therefore, to determine if combinations of cytokines (IL-6 or G-CSF) and bryostatin or TPA could have a direct stimulatory action on single colony-forming cells, limiting dilution (single cell) plating assays were performed. In the presence of bryostatin (IO-' mol/L) or TPA (100 ng/mL), no colony formation was observed in 204 wells. In the assays containing G-CSF or IL-6, the number of colonies formed were 6 and 5, respectively, TPA. 100 ng/mL; G-CSF, 5,000 U/mL; IL-6, 100 U/mL.
per 204 wells. These figures were increased to 20 and 22 if TPA (100 ng/mL) was also present. Similarly, the addition of bryostatin ( 10-8 mol/L) with IL-6 or G-CSF led to the formation of 11 and 22 colonies, respectively.
PKC uctivutors and cytokines need to be present ut the same time to promote colony formation. Having established that there is a synergistic interaction between IL-6 or G-CSF and activators of PKC, we then determined whether both growth factors and PKC activators must be present at the same time to achieve this synergy. We delayed the addition of cytokines to colony-forming assays for a period of 1 to 6 days, and assessed the effect on the number of colonies formed 7 days after the second addition (Fig 4) . Although the TPA was capable of maintaining the colony-forming potential of the GM-CFC, such that the addition of IL-6 or G-CSF after 1 to 4 days gave a significantly higher colony-forming efficiency than observed with IL-6 or G-CSF alone, there was a continuous loss in the number of colony-forming cells the longer the second addition was delayed. This was also observed when either G-CSF or IL-6 were present throughout the assay and the addition of TPA was delayed, indicating that both the CSF and the PKC activator must be present simultaneously to achieve optimal levels of colony formation.
In other cell types, combinations of mitogens interact synergistically to promote DNA synthesis. Measurement of [3H]-thymidine incorporation showed that the sole addition of G-CSF, IL-6, bryostatin, or TPA can stimulate DNA synthesis (Fig 5) , but there was no evidence of a synergistic interaction For personal use only. on July 15, 2017. by guest www.bloodjournal.org From between the cytokines (IL-6 and G-CSF) and the activators of PKC, although in some instances an additive effect was observed (Fig 5) . Thus, whereas marked effects on colony formation are observed, these are not attributable to a marked increase in the proliferative rate of the cells.
Another observation made with a large variety of cell types is that prolonged incubation with compounds such as TPA can lead to the down modulation of PKC isozymes, although the rate at which this may occur vanes between different populations of ~e l l s .~~,~~ To test whether or not this is the case in GM-CFC, we used Western blotting with anti-PKC antibodies to assess the levels of PKC present in GM-CFC when cultured in G-CSF or IL-6 plus TPA (100 ng/mL) or bryostatin ( mol/L) for 48 hours. The levels of PKC were not significantly diminished by the presence of either PKC activator (results not shown). Furthermore, for a period of greater than 72 hours after the cultures were established, TPA and bryostatin, respectively, stimulated an increase in the level of [3H]-thymidine incorporation, suggesting that downmodulation of PKC was not leading to a reduced response to PKC activators in GM-CFC. Therefore, it seems likely that the effects of direct activators of PKC and cytokines on GM-CFC are attributable to their continuous interaction during the development of the cells. However, it should be stressed that no colony formation is observed in GM-CFC with PKC activators alone.
TPA and bryostatin promote the formation of macrophages from GM-CFC. G-CSF and IL-6, respectively, stimulated the formation of neutrophilic colonies from GM-CFC (see Table 1 ). When TPA was also present, there was not only a change in the number and type of colonies formed (Table I and Fig 1) but also the type of mature cells formed from the GM-CFC ( Table 2 ), in that the proportion of macrophages present was now increased from 2% (with G-CSF present in the colony-forming assays) and 4% (with IL-6 present) to 84% and 8796, respectively, when TPA was also present in the colony-forming assays (see Table 2 ). Bryostatin also caused a marked increase in the proportion of neutrophil/ macrophage and macrophage colonies with a concomitant increase in the total number of macrophages produced in colony-forming assays compared with those where either IL-6 or G-CSF alone was present (Tables I and 2) .
A similar increase in both the total number of cells and also the number of macrophages formed from GM-CFC was observed in liquid culture. In the presence of G-CSF and IL- The concentrations of additives were: bryostatin, 1 O-' mol/L; TPA, 100 ng/mL; IL-6, 100 U/mL; G-CSF, 5,000 U/mL. The morphology of the cells formed in colony-forming assays were determined by pooling cells from 50 colonies and determining the proportion of each cell type Dresent.
6 there was an increase in the proportion of macrophages present if TPA or bryostatin, respectively, were also present (Table 3) .
DISCUSSION
The high plating efficiency of GM-CFC cultured in the presence of IL-3, GM-CSF, or M-CSF and the relatively poor plating efficiency of GM-CFC achieved in response to G-CSF and IL-6 has been noted previo~sly.l~~,~-' One possible reason for the reduced response seen with IL-6 or G-CSF is that the growth factors can stimulate only a small subpopulation of the GM-CFC. However, we have shown that the majority of GM-CFCs are initially responsive to G-CSF (in proliferation assays), but in soft agar-based assays, the majority of these cells fail to form colonies.* In other words, for the majority of the cells, the proliferative response is not maintained over the several cell divisions required for colony formation. Because ofthis we investigated the possibility that G-CSF requires the presence of a second mitogen to promote colony formation, as has been observed in the case of growth factor-promoted colony development of highly enriched populations of multipotent In colony-forming assays using GM-CFC-enriched using flow cytometric techniques,16 the level of growth factor (GM-CSF) required for maximal levels of colony formation is markedly reduced when phorbol esters were added to the assays. This indicated to us that there may be some potential role for PKC activation in potentiating the response of GM-CFC to G-CSF or IL-6.
Therefore, we assessed the effects of PKC activation on the proliferation, development, and colony formation from GM-CFC in the presence of a range of different cytokines. We have confirmed previous observations that activators of PKC do not act directly on progenitor cells to promote colony formation; however, in liquid culture there is evidence of a limited increase in cell number plus development of GM-CFC to macrophages (Table 3) . This, coupled with data on TPA-or bryostatin-mediated increases in [3H]-thymidine incorporation (Fig 5) , suggests that a limited degree of cell proliferation can be promoted by PKC activation, but this is insufficient to stimulate colony formation. Also, the maximal level of colony formation is not markedly altered when the phorbol ester TPA is added with M-CSF or GM-CSF, whereas
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From there is a small increase in the number of colonies produced when IL-3 is added with TPA. The most marked effect of PKC activators was when they were added with agents that have relatively poor colony-stimulating activity on GM-CFC. Our results show that the continued presence of either G-CSF or IL-6 with PKC activators leads to a synergistic effect on the number of colonies formed. The PKC activators can persistently stimulate [3H]-thymidine incorporation while the GM-CFCs develop in liquid culture, suggesting that the cells do not become desensitized to the effects of TPA or bryostatin via the down modulation of PKC.
One significant point concerning the data we have derived is the observation that bryostatin can act directly on hematopoietic progenitor cells and that its actions are not solely attributable to the stimulation of growth factor production by accessory ~e l l s . *~,~~ Plainly, however, there is a requirement for the presence of a CSF such as G-CSF for this direct effect of bryostatin to be apparent. This synergistic interaction between bryostatin and some CSFs may be of some relevance to the stimulation of hematopoiesis by bryostatin in vivo.27
It might be anticipated that growth factors or hormones capable of stimulating PKC would also be capable of interacting synergistically to promote the development of GM-CFC. Platelet-derived growth factor (PDGF) is one agent that is capable of activating C kinase, via the stimulation of inositol lipid hydr~lysis.'~,~~ This may be associated with the ability of PDGF to promote the formation of mature myeloid cells in vitro,30 although at present there is no evidence to suggest that there is a direct effect of PDGF on GM-CFC. Similarly, it is possible that muscarinic agonists, which can couple to inositol lipid hydroly~is,~'.~~ may act directly on GM-CFC to promote proliferation and maturation in the presence of G-CSF or other hematopoietic growth factors. 33 We are currently examining these possibilities.
Another growth factor that is known to activate PKC is M-CSF,34,35 although this has only been observed in monocytes and not progenitor cells at present. However, it is possible that the lineage restriction imposed on GM-CFC by M-CSF might be a consequence of PKC activation. It will be necessary to define the cellular signaling events elicited by M-CSF and other growth factors in GM-CFC to clarify this point. Also, because PKC is readily activated by a wide range of extracellular agents, this may be of some significance in the regulation of lineage restriction by growth factors. Exogenous stimuli that may not necessarily stimulate colony formation could, therefore, determine the type of mature cell produced from GM-CFC by potentiating the response of these cells to CSFs. For example, we have recently shown that interferon-y can markedly increase the proportion of macrophages produced from GM-CFC in soft agar assays containing G-CSF or IL-3.36 Whether this effect of interferon-y involves PKC activation awaits further investigation.
The data we present shows that there is a direct effect of PKC activators on the ability of GM-CFC to respond to G-CSF and IL-6, and possibly the commitment of these cells to either neutrophilic or macrophage development (as previously sugge~ted'~,'~). Although there remains a possibility that phorbol esters or bryostatin interact with G-CSF or IL-6 to selectively expand a population of developing cells, it is also possible that the combination of these agents may influence commitment to neutrophil or macrophage development. Part of the mechanism of leukemogenesis appears to involve the loss of the ability to differentiate or develop in response to stimuli such as CSFs. The altered responses of leukemic cells to growth factors that lead to a proliferation without development may involve a short-circuiting of the normal cellular signaling responses seen in progenitor cells. Using elutriated GM-CFC, we have an enriched target cell population with which we can elucidate the intracellular signaling mechanisms associated with lineage restriction in GM-CFC and determine whether there is a physiologic role for PKC in these events.
